Cryo-Cell International, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Stock Options (Tables)

Stock Options (Tables)

9 Months Ended

Aug. 31, 2013

Significant Option Groups Outstanding and Exercisable Option and its Price and Contractual Life

Significant option groups outstanding and exercisable at August 31, 2013 and related price and contractual life information are as follows:


	Outstanding						Exercisable
Range of Exercise Prices	Outstanding		Weighted Average Remaining Contractual Life (Years)		Weighted Average Exercise Price		Outstanding		Weighted Average Exercise Price

$0.42 to $1.00		7,500		1.65	$	.78		7,500	$	.78
$1.01 to $ 2.00		533,426		7.18	$	1.70		506,134	$	1.69
$2.01 to $ 3.00		588,000		6.36	$	2.50		480,513	$	2.54

		1,128,926		6.72	$	2.11		994,147	$	2.10

Summary of Non-Vested Options

A summary of the status of the Company’s non-vested shares as of August 31, 2013, and changes during the nine months ended August 31, 2013, is presented below:


	Shares			Weighted Average Grant-Date Fair Value

Non-vested at November 30, 2012		251,403		$	1.77

Granted		36,000			1.58
Vested		(131,794	)		1.69
Forfeited		(20,830	)		1.84

Non-vested at August 31, 2013		134,779		$	1.78

Service-Based Vesting Condition Options [Member]

Fair Value of Options Granted

Variables used to determine the fair value of the options granted for the three and nine months ended August 31, 2013 and August 31, 2012 are as follows:


	Three Months Ended						Nine Months Ended
	August 31, 2013			August 31, 2012			August 31, 2013			August 31, 2012
Weighted average values:
Expected dividends		0	%		0	%		0	%		0	%
Expected volatility		108.75	%		115.76	%		110.46	%		112.50	%
Risk free interest rate		1.35	%		.74	%		1.15	%		.90	%
Expected life		5.0 years			5.0 years			5.0 years			5.6 years

Range of Expected Volatilities for Options

The range of expected volatilities for options issued during the nine months ended August 31, 2013 and August 31, 2012 are as follows:


Nine Months Ended August 31, 2013		Nine Months Ended August 31, 2012

108.75% - 114.99%		111.30% - 116.28%

Stock Option Activity for Options

Stock option activity for options with only service-based vesting conditions for the nine months ended August 31, 2013, was as follows:


	Shares			Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (Years)		Aggregate Intrinsic Value

Outstanding at November 30, 2012		1,183,098		$	2.15		7.12	$	580,730

Granted		36,000			2.00			$	7,490
Exercised		(10,000	)		1.50			$	5,575
Expired/forfeited		(80,172	)		2.67			$	12,925


Outstanding at August 31, 2013		1,128,926		$	2.11		6.72	$	300,637

Exercisable at August 31, 2013		994,147		$	2.10		6.87	$	287,792

Performance and Market-Based Vesting Condition Options [Member]

Fair Value of Options Granted

Variables used to determine the fair value of options with performance-based and market-based vesting conditions granted during the nine months ended August 31, 2012 are as follows:


	Nine Months Ended August 31, 2012

Weighted average values:
Expected dividends		0	%
Expected volatility		107.03	%
Risk free interest rate		1.00	%
Expected life		6.4 years

Range of Expected Volatilities for Options

The range of expected volatilities for performance-based and market-based vesting condition options issued during the nine months ended August 31, 2012 are as follows:


		Nine Months Ended August 31, 2012

		111.3% - 113.5%

Stock Option Activity for Options

Stock option activity for options with performance-based and market-based vesting conditions for the nine months ended August 31, 2013, was as follows:


	Shares		Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (Years)		Aggregate Intrinsic Value

Outstanding at November 30, 2012		640,000	$	1.74		8.83	$	511,600

Granted		—		—
Exercised		—		—
Expired/forfeited		—		—

Outstanding at August 31, 2013		640,000	$	1.74		8.08	$	300,000

Exercisable at August 31, 2013		—		—		—		—